Advertisement

Topics

Nature’s Sunshine Products Reports Third Quarter 2017 Financial Results

11:40 EST 8 Nov 2017 | BioMedReports - Blog

  • Third quarter net sales of $89.3 million were up 4.5 percent year-over-year 
  • Net income of $2.4 million attributable to common shareholders, or $0.13 per diluted common share during the third quarter
  • Third quarter Adjusted EBITDA of $4.7 million

LEHI, Utah, Nov. 08, 2017 (GLOBE NEWSWIRE)

Read more...

Original Article: Nature’s Sunshine Products Reports Third Quarter 2017 Financial Results

NEXT ARTICLE

More From BioPortfolio on "Nature’s Sunshine Products Reports Third Quarter 2017 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...